Clinical trial

Methotrexate (Rheumatrex) High Dose Special Investigation (Regulatory Post Marketing Commitment Plan)

NCT01414257

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2011-05-01

PhaseN/A

Study timeline

Study start (actual)2011-05-01Date precision: month

Registry last updated2018-08-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Arthritisunresolved

Rheumatoidunresolved

High Doseunresolved

Interventions

Methotrexate (MTX)DRUG

Sponsors & collaborators

Pfizerlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01414257 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.